Schroder Investment Management Group
TXG icon

Schroder Investment Management Group’s 10x Genomics TXG Stock Holding History

Schroder Investment Management Group’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4,269
Closed -$319K – 1391
2022
Q1 		$319K Sell
4,269
-268
-6% -$23.4K ﹤0.01% 1265
2021
Q4 		$676K Sell
4,537
-2,597
-36% -$398K ﹤0.01% 1082
2021
Q3 		$1.04M Buy
7,134
+3,850
+117% +$661K ﹤0.01% 1095
2021
Q2 		$643K Sell
3,284
-13,956
-81% -$2.53M ﹤0.01% 1201
2021
Q1 		$3.12M Sell
17,240
-4,712
-21% -$814K ﹤0.01% 925
2020
Q4 		$3.11M Buy
21,952
+962
+5% +$140K ﹤0.01% 914
2020
Q3 		$2.69M Buy
20,990
+1,510
+8% +$159K ﹤0.01% 842
2020
Q2 		$1.74M Buy
19,480
+3,345
+21% +$261K ﹤0.01% 847
2020
Q1 		$1M Hold
16,135
– – ﹤0.01% 903
2019
Q4 		$1.23M Sell
16,135
-3,865
-19% -$232K ﹤0.01% 940
2019
Q3 		$1.01M Buy
+20,000
New +$1.11M ﹤0.01% 985

Other funds holding TXG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Schroder Investment Management Group's TXG Position: Q2 2022 in Review

Schroder Investment Management Group sold out of 10x Genomics (TXG) in Q2 2022, closing a stake of 4,269 shares — an estimated $319K sold.

Schroder Investment Management Group first reported a position in TXG in Q3 2019 and held it in 11 quarters. The position peaked at $3.12M in Q1 2021. 254 funds tracked by Wall St. Rank hold TXG as of Q2 2022.

  • Schroder Investment Management Group reported no remaining 10x Genomics position as of Q2 2022 after selling out during the quarter.
  • Schroder Investment Management Group sold 4,269 10x Genomics shares in Q2 2022, an estimated $319K.
  • Schroder Investment Management Group first reported a position in 10x Genomics in Q3 2019 and held it in 11 quarters.
  • Schroder Investment Management Group's 10x Genomics position peaked at $3.12M in Q1 2021.
  • 254 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2022.

Based on Schroder Investment Management Group's 13F filing for Q2 2022, filed 11 Aug 2022.